Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease

Spina, Salvatore, La Joie, Renaud, Petersen, Cathrine, Nolan, Amber L, Cuevas, Deion, Cosme, Celica, Hepker, Mackenzie, Hwang, Ji-Hye, Miller, Zachary A, Huang, Eric J, Karydas, Anna M, Grant, Harli, Boxer, Adam L, Gorno-Tempini, Maria Luisa, Rosen, Howard J, Kramer, Joel H, Miller, Bruce L, Seeley, William W, Rabinovici, Gil D, Grinberg, Lea T·2021·Brain
DOI 10.1093/brain/awab099

Cited by (278)

Items 201–278 of 278

  1. Telomere length, in vivo Alzheimer’s disease pathologies and cognitive decline in older adults
    Joon Hyung Jung, Min Soo Byun, Dahyun Yi, Hyejin Ahn, Jun Ho Lee, Jang-Seok Lee, Hyun‐Seob Lee, Jun‐Young Lee, Yu Kyeong Kim, Yun‐Sang Lee et al. · 2024 · Journal of Neurology Neurosurgery & Psychiatry
  2. Identifying dementia neuropathology using low‐burden clinical data
    Yueqi Ren, Babak Shahbaba, Craig E.L. Stark · 2025 · Alzheimer s & Dementia
  3. Amygdala-predominant Lewy bodies associate with cognitive decline and amygdala atrophy in Alzheimer’s disease neuropathological change
    Francisco Almeida, Alexandra C. Santos, Tiago Jesus, Kathryn M. Gauthreaux, Charles Mock, Walter A. Kukull, John F. Crary, Tiago Gil Oliveira · 2025 · Journal of Neurology
  4. Examining real-world Alzheimer’s disease heterogeneity using neuroanatomical normative modelling
    Flavia Loreto, Serena Verdi, Seyed Mostafa Kia, Aleksandar Duvnjak, Haneen Hakeem, Anna Fitzgerald, Neva Patel, Johan Lilja, Zarni Win, Richard J. Perry et al. · 2022 · medRxiv
  5. An electrostatic cluster guides Aβ40 fibril formation in cerebral amyloid angiopathy
    Elliot J. Crooks, Ziao Fu, Brandon A. Irizarry, Xiaoyue Aelita Zhu, William E. Van Nostrand, Saikat Chowdhury, Steven O. Smith · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Divergent enlarged perivascular spaces volumes in early versus late age-of-onset Alzheimer’s disease
    Kyan Younes, Yann Cobigo, Tori Tsuie, Earnest Wang, Amy A. Wolf, Renaud La Joie, David N. Soleimani‐Meigooni, Breton Michael Asken, Duygu Tosun, Joel H. Kramer et al. · 2023 · medRxiv
  7. Alzheimer’s disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era
    Luca Sofia, Federico Massa, Matteo Pardini, Dario Arnaldi, Matteo Bauckneht, Silvia Daniela Morbelli · 2024 · European Journal of Nuclear Medicine and Molecular Imaging
  8. Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer’s disease
    Anika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, Olof T. Strandberg, Erik Stomrud, Niklas Mattsson, Shorena Janelidze, Ruben A Smith, Sebastian Palmqvist, Hannah Baumeister et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Tau-Associated Neuronal Loss in the Intermediate Nucleus of the Human Hypothalamus (VLPO Analog): Unveiling the Basis of NREM Sleep Dysfunction in PSP and Alzheimer’s Disease
    Shima Rastegar‐Pouyani, Caroline Horton Lew, Felipe L. Pereira, Abhijit Satpati, Vítor Ribeiro Paes, Renata Elaine Paraízo Leite, Cláudia Kimie Suemoto, Salvatore Spina, Helmut Heinsen, William W. Seely et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Association of [ 18 F]Flortaucipir-PET and plasma p-tau217 with tau neuropathology in AD and other neurodegenerative disorders
    Agathe Vrillon, Salvatore Spina, Jhony Alejandro Mejía‐Perez, Tia LaMore, Claire Yballa, David N. Soleimani‐Meigooni, Ganna Blazhenets, Adam L. Boxer, Julio C. Rojas, Argentina Lario Lago et al. · 2025 · medRxiv
  11. Dysexecutive Alzheimer’s Disease with Lewy Body Disease Co-Pathology
    Ryan P Coburn, Hugo Botha, Jonathan Graff‐Radford, Robert Ross Reichard, David Thomas Jones, Vijay K. Ramanan · 2022 · Current Alzheimer Research
  12. Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease
    Xiao Luo, Hui Hong, Shuyue Wang, Kaicheng Li, Qingze Zeng, X B Liu, Luwei Hong, Jixuan Li, Xinyi Zhang, Siyan Zhong et al. · 2025 · Journal of Alzheimer s Disease
  13. Sex and ethnicity in early‐onset Alzheimer's disease biomarkers and global function
    Breton Michael Asken, Wei‐en Wang, Franchesca Arias, Shellie-Anne T. Levy, Warren Barker, Mónica Rosselli, Rosie E. Curiel, Michael Marsiske, Melissa J. Armstrong, David E. Vaillancourt et al. · 2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  14. Impact of Lewy body and limbic-predominant TDP-43 neuropathology on cognitive and neuropsychiatric trajectory in Alzheimer’s disease: a retrospective neuropathological study
    Jarok Koo, H.S. Lee, Yoo Shin Choi, Kyoungwon Baik, Mincheol Park, Alzheimer’s Disease Neuroimaging Initiative · 2026 · Frontiers in Aging Neuroscience
  15. Dementia with Lewy Bodies: Updates in Diagnosis and Management
    Mayra I. Guindin-Orama, Valeria Soto-Martínez, Laura I. van Dyck, Kirsten M. Wilkins · 2025 · Current Geriatrics Reports
  16. Cognitive stimulation exerts long-lasting protective effects on the hippocampal vasculature and memory function in a rat model of vascular cognitive impairment
    Abbie C. Chapman, Anduela Thaqi, Risa L. Kalish, Brian Deng, Gianna M. DeMarco, Aleena Shehryar, Emily J. Baumoel, Phoebe Bergson, Simon Papavangjeli · 2025 · npj Aging
  17. Alzheimer's disease and mixed pathologies as a hidden contributor to fatal hypothermia: A large‐scale forensic autopsy‐based study
    Shojiro Ichimata, Koji Yoshida, Ryo Tanaka · 2025 · Brain Pathology
  18. Greater locus coeruleus vulnerability in atypical clinicopathologic forms of Alzheimer's disease
    Sara Rose Dunlop, Billie J. Matchett, Alexander Mannsbart, Fadi S. Hanna Al‐Shaikh, Zhongwei Peng, Darren M. Rothberg, Jessica F. Tranovich, Ranjan Duara, Idaly Vélez-Uribe, Joselen Gondrez et al. · 2026 · Alzheimer s & Dementia
  19. Mixed primary progressive aphasia and alcohol use disorder: a case of detailed clinical phenotyping outperforming molecular imaging
    Obiora Okoye, Cristiano Schaffer Aguzzoli, Petronilla Battista, Claudia Ramos, Karen Patricia Meenan, Maison Abu Raya, Buddhika M. Ratnasiri, Julio C. Rojas, Jessica de Leon, Bruce L. Miller et al. · 2026 · Neurocase
  20. Neuropsychiatric Symptoms in Patients With Pathologically Confirmed Comorbid Alzheimer Disease and Frontotemporal Lobar Degeneration
    Daliah Ross, Molly Split, Zachary J. Kunicki, Rachel M. Keszycki, Sarah Prieto, Alyssa N. De Vito, Masood Manoochehri, Edward D. Huey, Megan S. Barker · 2026 · Neurology
  21. The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls
    Juho-Antti Rissanen, Sari Kärkkäinen, Kasper Katisko, Aleksi Vanninen, Antti Johannes Luikku, Tuomas H. Rauramaa, Tadeusz Musialowicz, Merja Kokki, Valtteri Julkunen, Anne M. Portaankorva et al. · 2026 · Journal of Alzheimer s Disease
  22. Frequency of mixed neuropathologies in individuals with Down syndrome with and without Alzheimer's dementia
    Lisi Flores Aguilar, Thomas D. Zaikos, Isabel Rivera, Sierra T. Wright, Jerry Lou, Brianna Gawronski, Lourdes Gonzalez, Jillian V. Berry, Jeremy P. Rouanet, Natalie C. Edwards et al. · 2026 · Acta Neuropathologica
  23. TDP-43: a critical amplifier of Alzheimer’s disease beyond amyloid and tau
    Abhideep Roy, Sushila Chhetry, Hiramoni Deka, Rubina Roy, Pallab Bhattacharya, Basant Kumar Patel, Anupom Borah · 2026 · Neuroscience
  24. Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action
    Nick Corriveau‐Lecavalier, Neus Falgàs, Deepti Putcha, Jonathan Graff‐Radford, Keir X. X. Yong, Baayla D.C. Boon, Rosaleena Mohanty, Eric Westman, Colin Groot, David Thomas Jones et al. · 2026 · Alzheimer s & Dementia
  25. Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes
    Dror Shir, Nick Corriveau‐Lecavalier, David Thomas Jones, Vijay K. Ramanan, Christian Lachner, David S. Knopman, Ronald Carl Petersen, Keith A. Josephs, Gregory Scott Day, Jonathan Graff‐Radford et al. · 2026 · Neurology
  26. Targeting intra‐tumoral heterogeneity of human brain tumors with in vivo imaging: A roadmap for imaging genomics from multiparametric MR signals
    Jason G. Parker, Mahsa Servati, Emily E. Diller, Sha Cao, Chang Yueh Ho, Robert M. Lober, Aaron Cohen‐Gadol · 2022 · Medical Physics
  27. Prediction of Co-Occurrence of Lewy Body Disease with Alzheimer’s Disease
    Kenichi Hashiguchi, Ryota Kobayashi, Daichi Morioka, Shinobu Kawakatsu, Kazutaka Sakamoto, Hiroshi Matsuda, Akihito Suzuki · 2024 · Journal of Alzheimer s Disease Reports
  28. Transposable Elements in Human Diseases: Evolutionary and Therapeutic Perspectives
    Kavi Shah, Ahmet Can Berkyurek · 2022 · Preprints.org
  29. Boston criteria version 2.0 and non-haemorrhagic presentations
    João Moura, Luı́s F. Maia · 2023 · The Lancet Neurology
  30. Unraveling the Complex Pathology of Neurodegenerative Diseases: Multiple Prions, Cross-β Networks and Baicalein's ReproFold
    Hsiang‐Yu Chang, I‐Fan Wang · 2024 · Preprints.org
  31. Effects of α-synuclein pathology in normal aging and Alzheimer’s disease
    Joseph R. Winer, Melanie J. Plastini, America Romero, Hillary A. Vossler, Isha Sai, Divya Channappa, Carla Abdelnour Ruiz, Marian Shahid, Edward N. Wilson, Christina B. Young et al. · 2025 · medRxiv
  32. Evidence of Rising Neurological Mortality and Examining Multiple-Interactive Environmental Causes in the 21stCentury
    Colin W. Pritchard, Anne Silk, Lars Hansen · 2022 · Medical Research Archives
  33. Preface
    HARI SHANKER SHARMA, Lars Wiklund, Aruna Sharma · 2023 · International review of neurobiology
  34. ‘Hidden epidemic’ of neurological deaths in the major Western nations in the 21st Century
    Colin W. Pritchard · 2024 · Social Work and Social Sciences Review
  35. Alzheimer’s disease and neurodegeneration in symptomatic cerebral small vessel disease
    Philipp Arndt, Malte Pfister, Valentina Perosa, Hendrik Mattern, José Bernal, Anna-Charlotte John, Marc Dörner, Patrick Müller, Ruediger Christian Braun-Dullaeus, Cornelia Garz et al. · 2024 · medRxiv
  36. Implications of treatment duration and frequency for value and cost-effective price of Alzheimer treatments
    Soeren Mattke, Tabasa Ozawa, Mark Hanson · 2024 · Journal of Managed Care & Specialty Pharmacy
  37. Clinicopathologic Characterization of 2 Individuals With TBK1 Variants—1 Novel Splice Variant, 2 Proteinopathies
    Kimiko Domoto‐Reilly, B. Jane Distad, Danny E. Miller, Yi-Han Lin, David Ivanick, Andrew S. Warren, Suman Jayadev, Caitlin S. Latimer · 2024 · Neurology Genetics
  38. Influence of the Glymphatic System on α-Synuclein Propagation: Role of Aquaporin-4 and the Dystrophin-Associated Protein Complex
    Douglas M. Lopes, Sophie K. Llewellyn, Sheila E Bury, Jiazheng Wang, Jack A. Wells, Matthew E. Gegg, Guglielmo Verona, Mark F. Lythgoe, Ian F. Harrison · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Alzheimer’s Disease
    Simon Gerhand · 2024 · Cambridge University Press eBooks
  40. Identifying Dementia Lewy Bodies in Alzheimer Dementia: Case Report
    Christophorus Aditya Pawitan, Yulia Fatima Bessing, Erikavitri Yulianti · 2025 · Research Journal of Pharmacy and Technology
  41. AB42 alters glutamatergic transmission in the CA1 region of the mouse hippocampus
    Patrick H. Wehrle · 2022 · Scholars Archive - University at Albany (University at Albany, State University of New York)
  42. Are Australians living with dementia ready for new therapies?
    Sean Maher, Ranjeev Chrysanth Pulle · 2025 · Internal Medicine Journal
  43. Ephaptic conduction molding memory engrams
    A. Rabinovitch, Revital Rabinovitch, Doron Braunstein, Ella Smolik, Yaacov Biton · 2025 · BMC Biology
  44. Systematic Review of glucose transporter alterations in human Alzheimer’s disease and rodent Alzheimer’s disease models
    Eva Hede, Annette Burkhart, Blanca I. Aldana, Kristi A. Kohlmeier, Torben Moos, Maj Schneider Thomsen · 2025 · Research Square
  45. Enrichment of patients with concomitant LATE on the Alzheimer’s disease continuum using hippocampal volume
    Nidhi S. Mundada, Xueying Lyu, Christopher Brown, Niyousha Sadeghpour, Emily McGrew, Long Xie, Philip A. Cook, James C. Gee, Paul A. Yushkevich, Sandhitsu R. Das et al. · 2025 · medRxiv
  46. Integration of wearable devices and artificial intelligence in Alzheimer’s disease: A scoping review protocol
    Wenhao Qi, Yankai Shi, Shiying Shen, Bingsheng Wang, Shuai Zhang, Junling Kang, Xiaodong Lü, Guowei Jiang, Lizzy Mitzy Maria Boots, Qian Xu et al. · 2025 · PLoS ONE
  47. Distinct brain atrophy patterns in Lewy body disease: The impact and interaction of comorbid neuropathologies revealed by voxel-based morphometry
    Shohei Inui, Daita Kaneda, Keita Sakurai, Yuto Uchida, Satoru Morimoto, Osamu Abe, Yoshio Hashizume · 2025 · Journal of Alzheimer s Disease
  48. Alzheimer’s Disease: Preclinical to Advanced Dementia
    Neus Falgàs Martínez, Raquel Sánchez‐Valle · 2025 · Cambridge University Press eBooks
  49. Additional file 1 of Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South Korea
    Min Young Chun, Wonjeong Chae, Seo, Sang Won, Jang, Hyemin, Yun, Jihwan, Na, Duk L., Dongwoo Kang, Lee, Jungkuk, Dustin B. Hammers, Liana G. Apostolova et al. · 2024 · Figshare
  50. Additional file 2 of Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
    Anika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, Olof T. Strandberg, Erik Stomrud, Niklas Mattsson, Shorena Janelidze, Smith, Ruben, Sebastian Palmqvist, Hannah Baumeister et al. · 2024 · Figshare
  51. Additional file 1 of Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
    Anika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, Strandberg, Olof, Erik Stomrud, Niklas Mattsson, Shorena Janelidze, Smith, Ruben, Sebastian Palmqvist, Hannah Baumeister et al. · 2024 · Figshare
  52. Additional file 1 of LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease
    Marta J. Koper, Sandra O. Tomé, Klara Gawor, Annelies Belet, Evelien Van Schoor, Jolien M. Schaeverbeke, Rik R. Vandenberghe, Mathieu Vandenbulcke, Estifanos Ghebremedhin, Markus Otto et al. · 2022 · Figshare
  53. Additional file 1 of Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment
    Nidhi S. Mundada, Julio C. Rojas, Vandevrede, Lawren, Elisabeth H. Thijssen, Leonardo Iaccarino, Obiora Okoye, Ranjani P. Shankar, Soleimani-Meigooni, David N., Argentina Lario Lago, Bruce L. Miller et al. · 2023 · Figshare
  54. Galantamine–Escitalopram Combination Therapy in Alzheimer’s Comorbid Depression Model in Mice: Role of BDNF/KYN Pathways, Neuroinflammation, and Oxidative Stress
    Shivanshu Bajaj, Radhakrishnan Mahesh · 2026 · ACS Omega
  55. A split biotin ligase approach reveals proteins associated with oligomeric alpha-synuclein during aggregation
    Analiese R. Fernandes, Abigail Owen, Ayman H. Faroqi, Jannifer H. Lee, Gunveen S. Sachdeva, Dmytro Morderer, Cody Hoffmann, Benjamin J. Madden, Shuwen Zhang, Yingxue Ren et al. · 2026 · Scientific Reports
  56. Distinct associations of corticolimbic hypometabolism and atrophy patterns correlate with postmortem neuropathologies in cognitively impaired individuals
    Sophia Wheatley, Daniel Ferreira, Agneta Nordberg, Rosaleena Mohanty, Eric Westman · 2026 · Research Square
  57. Parthenolide Ameliorates Alzheimer’s Disease Pathology by Suppressing Microglial Inflammation and Inflammation-Driven Amyloidogenesis via the HIF1α/NF-κB Axis
    Xin Liu, Jie Liu, Pei-yang Wang, Jun-He Cui, Yu-meng Bu, Shan-shan Wu, Yanhui Zhang, Chuang Guo · 2026 · ACS Chemical Neuroscience
  58. Reframing Alzheimer's disease as a complex adaptive system: More than an amyloid beta–tau connection
    Maurizio Giorelli · 2026 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  59. Early-onset Alzheimer's disease mortality in the United States: A population-based study of trends and disparities, 2015–2024
    Ali Al‐Salahat, Ali Bin Abdul Jabbar, Keara Kennedy, Andy Song, Maura Hackett, Majd A. AbuAlrob, Himanshu Verma, Jagkirat Singh, Evanthia Bernitsas · 2026 · Journal of Alzheimer s Disease
  60. Blood biomarkers for Alzheimer's disease: from detection to decisions
    Marc Suárez‐Calvet, Gemma Salvadó, Beatriu Bilbeny de Fortuny, Marta del Campo · 2026 · The Lancet
  61. Identification of patients receiving amyloid‐targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS
    Renaud La Joie, Ganna Blazhenets, Piyush Maiti, Konstantinos Chiotis, Ani Eloyan, Kala Kirby, Dustin B. Hammers, Robert A. Koeppe, Sarah F. Ackley, Justin Robison et al. · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  62. Cerebrovascular reactivity and plasma p‐tau181 in Alzheimer's disease: Insights into APOE‐related vascular phenotypes
    Martina Gaia Di Donna, Maria Rosaria Bagnato, Chiara Giuseppina Bonomi, Caterina Motta, Diego Centonze, Alessandro Martorana, Marina Diomedi · 2026 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  63. Targeted proteomics of postmortem human brain reveals neurobiologic heterogeneity in Alzheimer’s disease using NULISA technology
    Sara Rose Dunlop, Sarah Lincoln, Zhongwei Peng, Neill R. Graff‐Radford, Christian Lachner, Gregory Scott Day, Jessica F. Tranovich, Robert Ross Reichard, Dennis W. Dickson, Ronald Carl Petersen et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Diagnostic delay in early-onset Alzheimer’s disease in Japan: a retrospective study
    Kensaku Kasuga, Soichiro Shimizu, Noriyuki Kimura, Koji Kasanuki, Shu Sakurai, Shuntaro Serisawa, Teruaki Masuda, Takuya Ataka, Masanori Tadokoro, Chiaki Hashimoto et al. · 2026 · BMC Neurology
  65. Clinicopathological and molecular heterogeneity of amyloid‐β in unnatural deaths under 70 years: A forensic autopsy–based study
    Shojiro Ichimata, Yukiko Hata, Kōji Yoshida, Ryo Tanaka, Shigeo Murayama · 2026 · Brain Pathology
  66. Chronic hypertension and social isolation disrupt the blood-brain barrier and memory in a sex-dependent manner
    Anduela Thaqi, Gianna M. DeMarco, Emily D. Schellinger, Dinlin Chen, Jared Luchetta, Abbie C. Chapman · 2026 · Neurobiology of Disease
  67. Dementias
    Julia Czech, Charlotte S. Weyland, Manuela Neumann, Alexander E. Drzezga, Jörg Bernhard Schulz · 2026 · Springer eBooks
  68. Clinical utility of skin biopsy detection of phosphorylated alpha-synuclein in an outpatient practice
    Todd Levine, Roy Freeman, Nicole Murray, Alexandria Swanson, Colin Gibbons, Jason Crowell, Justin Phillips, Christopher H. Gibbons · 2026 · Frontiers in Neurology
  69. Tau‐associated neuronal loss in the intermediate nucleus of the human hypothalamus, a putative VLPO analog, in progressive supranuclear palsy and Alzheimer's disease
    Shima Rastegar‐Pouyani, Caroline Horton Lew, Felipe Luiz Pereira, Abhijit Satpati, Ana Moreno Arnas, Vítor Ribeiro Paes, Renata Elaine Paraízo Leite, Cláudia Kimie Suemoto, Salvatore Spina, Gowoon Son et al. · 2026 · Alzheimer s & Dementia
  70. TMEM106B is a selective modulator of TDP‐43 pathology in Alzheimer's disease
    Madison M. Reeves, Anna Calliari, Tiffany W. Todd, Candela Maroto Cidfuentes, Karen R. Jansen‐West, Mei Yue, Yuping Song, Judith A. Dunmore, Bailey D. Rawlinson, Erica Engelberg-Cook et al. · 2026 · Alzheimer s & Dementia
  71. Alzheimer's disease heterogeneity and co‐pathologies: Defining novel targets, biomarkers, modalities, and research methodologies
    Malú G. Tansey, Sasha Bozeat, Peter Ackerman, Alireza Atri, Christopher J. Barnum, Patrik Brundin, Carlos M Abreu de Carvalho, Adam Fleisher, Ana Graf, Elizabeth Head et al. · 2026 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  72. A new era of genome-wide association studies in the field of Alzheimer’s disease and overlapping co-pathologies: lessons learned from a neuropathology-centered approach
    Celeste Laureyssen, Dietmar Rudolf Thal, Kristel Sleegers · 2026 · Acta Neuropathologica
  73. Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity
    Lea T. Grinberg, Melissa Erin Murray · 2026 · Nature Reviews Neurology
  74. European Association of Nuclear Medicine (EANM) Focus Meeting 7: Consensus on the role of molecular imaging and fluid biomarkers in diagnosis, treatment eligibility, and monitoring in Alzheimer's Disease
    Silvia Daniela Morbelli, Matthias Brendel, Nelleke Tolboom, Alexander E. Drzezga, Shorena Janelidze, Renaud La Joie, Luca Roccatagliata, Federica Agosta, Javier Arbizu, Cecilia Boccalini et al. · 2026 · The EANM Journal
  75. Network‐dependent remote effects and local tau burden jointly shape neuronal dysfunction in Alzheimer's disease
    Lukas K. Frontzkowski, Sebastian Niclas Roemer, Johannes S. Gnörich, Daniel Janowitz, Hannah Eyob, Katharina Probst, Dario Dhoqina, Anna Dewenter, Anna Steward, Zeyu Zhu et al. · 2026 · Alzheimer s & Dementia
  76. Plasma eMTBR‐tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes
    Jennifer Louise Whitwell, Jerusha G. Bhaskaran, Ryota Satoh, Jonathan Graff‐Radford, Mary M. Machulda, Val J. Lowe, Michelle M. Mielke, Dennis W. Dickson, Shin‐Cheng Tzeng, John Bui et al. · 2026 · Alzheimer s & Dementia
  77. Too early for LATE? Age at onset is associated with the clinical and neuroimaging expression of limbic-predominant age- related TDP-43 pathology in Alzheimer’s disease
    Nuole Zhu, Renaud La Joie, Isabel Elaine Allen, Marlene Lin, D. Luke Fischer, David N. Soleimani‐Meigooni, Howard J. Rosen, Maria‐Luisa Gorno‐Tempini, Zachary Miller, David C. Perry et al. · 2026 · medRxiv
  78. Quick Conclusions From Slowed Saccades: When Progressive Supranuclear Palsy Overshadows Lewy Body Disease
    D. Luke Fischer, Mark E. Sanderson‐Cimino, William W. Seeley, Renaud La Joie, Claire Yballa, Lawren A. VandeVrede, Bruce L. Miller, Lea T. Grinberg · 2026 · Cognitive and Behavioral Neurology